Last Updated: November 10, 2026

Wellhouse Pharma Company Profile

« Back to Dashboard


What is the competitive landscape for WELLHOUSE PHARMA

WELLHOUSE PHARMA has one approved drug.

There are four US patents protecting WELLHOUSE PHARMA drugs.

Summary for Wellhouse Pharma
US Patents:4
Tradenames:1
Ingredients:1
NDAs:1

Drugs and US Patents for Wellhouse Pharma

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wellhouse Pharma SYNDROS dronabinol SOLUTION;ORAL 205525-001 Mar 23, 2017 DISCN Yes No 9,345,771 ⤷  Start Trial Y Y ⤷  Start Trial
Wellhouse Pharma SYNDROS dronabinol SOLUTION;ORAL 205525-001 Mar 23, 2017 DISCN Yes No 11,253,472 ⤷  Start Trial Y Y ⤷  Start Trial
Wellhouse Pharma SYNDROS dronabinol SOLUTION;ORAL 205525-001 Mar 23, 2017 DISCN Yes No 8,222,292 ⤷  Start Trial Y Y ⤷  Start Trial
Wellhouse Pharma SYNDROS dronabinol SOLUTION;ORAL 205525-001 Mar 23, 2017 DISCN Yes No 10,265,293 ⤷  Start Trial Y Y ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Paragraph IV (Patent) Challenges for WELLHOUSE PHARMA drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Oral solution 5 mg/mL ➤ Subscribe 2017-04-17
➤ Subscribe Oral Solution 5mg/ml ➤ Subscribe 2017-04-17
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.